Special notice
Health Sector Supply Chain Fragility and Investment Prioritization Support Services
77344426S0002
United States International Development Finance Corporation, Office of Acquisition. Pharmaceutical Preparation Manufacturing.
Response deadline
August 31, 2026 at 4:30 PM EDT
Closed 62 days ago. Posted August 27, 2026. Scheduled to archive September 15, 2026.
Get the next one like this from United States International Development Finance Corporation by email, the day it is posted.Find my opportunities
This one closed in 2026
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes in 2 daysNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes in 2 daysNov 3
Description
As published on SAM.gov.
Notice of Sole Source Intent
The U.S. International Development Finance Corporation (DFC) intends to award a one-year, sole source purchase order to API Innovation Center (APIIC) for specialized analytical, technical, data integration, prioritization, reporting, and briefing support to identify, assess, prioritize, and act on pharmaceutical and health-sector supply chain vulnerabilities that may present development finance, investment, counter-dependency, resilience, and strategic supply chain opportunities. The requirement is for a highly specialized contractor capable of producing a national fragility analysis; integrating multiple pharmaceuticals, manufacturing, regulatory, utilization, geopolitical, and risk datasets; assessing API-level supply chain dependency; supporting DFC-calibrated model weighting; prioritizing candidate drugs; and preparing approximately 20–30 drug-specific supply chain reports. The work requires detailed visibility into active pharmaceutical ingredient (API) production, finished dosage form (FDF) manufacturing, key starting material (KSM) and upstream dependencies, manufacturer and facility-level concentration, country-specific dependency risks, and financeable opportunities to reduce supply chain fragility.
This contract action is for services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). Interested vendors may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received by Monday, August 31, 2026, at 4:30pm Eastern Time (ET) will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contracting Officer, Melissa Hergenrader, at melissa.hergenrader@dfc.gov by Monday, August 31, 2026, at 4:30pm ET.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 27, 2026
Special notice
Due August 31, 2026 at 4:30 PM EDT. SAM.gov, notice 8bb80217267a4e4eb12ca5bc59faf17a
1 revisions on SAM
- August 27, 2026: publish, special notice
Points of contact
- Melissa Hergenradermelissa.hergenrader@dfc.gov2029299434
- Aaron McKellumaaron.mckellum@dfc.gov